Statistics Around This
%
of COPD patients develop lung cancer every year
%
lifetime risk of developing COPD
most common cause of death (COPD) in the US
projected cost of COPD in the US
The Problem
![Research](https://betterlungs.ai/wp-content/uploads/2021/02/Research.png)
Adequate research studies are not available to leverage the linkage between these two diseases.
![Lungs](https://betterlungs.ai/wp-content/uploads/2021/02/Lungs.png)
COPD patients have twice the regular risk of lung cancer development. Currently, there are no AI predictive models around this.
![COPD](https://betterlungs.ai/wp-content/uploads/2021/02/COPD.png)
COPD is often stated as the driver of lung cancer.
![medicine](https://betterlungs.ai/wp-content/uploads/2021/02/medicine.png)
Anti-cancer drugs may play a role in the future of COPD treatment.
The Strategy
BetterLungs early warning platform can help in intervening in a timely, life-saving way.
Augmenting decision making with AI.
![](https://betterlungs.ai/wp-content/uploads/2021/01/S1.png)
Reports and imaging can be used to predict the risk of lung cancer in COPD patients prior to the pathogenesis of the disease.
![](https://betterlungs.ai/wp-content/uploads/2021/01/S2.png)
Our solution is to collect patient records and other relevant data into a data lake.
![](https://betterlungs.ai/wp-content/uploads/2021/01/S3.png)
Process patient information into machine learning algorithms to allow for detection of more nuanced patterns that may not be evident to human eye.
![](https://betterlungs.ai/wp-content/uploads/2021/01/s6.png)
The effective and accurate AI model can be harnessed by clinicians to order early cancer screening for COPD patients.